Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers

Br J Clin Pharmacol. 1994 Jan;37(1):79-81. doi: 10.1111/j.1365-2125.1994.tb04244.x.

Abstract

The effect of pretreatment with cimetidine (1 g day-1, 7 days) and of probenecid (1 g twice daily, 4 days) on the pharmacokinetics of tenoxicam (single oral dose, 20 mg) was studied in six healthy volunteers. Cmax was increased significantly when tenoxicam was given with probenecid (2.8 micrograms ml-1 alone, 3.5 micrograms ml-1 after probenecid; P < 0.005). No other pharmacokinetic parameters were altered significantly by either drug. It is concluded that neither cimetidine nor probenecid affects the pharmacokinetics of tenoxicam in a clinically important way.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / blood
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics*
  • Cimetidine / pharmacology*
  • Drug Interactions
  • Female
  • Humans
  • Male
  • Piroxicam / administration & dosage
  • Piroxicam / analogs & derivatives*
  • Piroxicam / blood
  • Piroxicam / pharmacokinetics
  • Probenecid / pharmacology*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Piroxicam
  • Cimetidine
  • Probenecid
  • tenoxicam